News|Articles|August 14, 2026

Maternity care deserts persist, virtual pelvic PT gains ground, ABCL635 phase 2 hot flash data

Fact checked by: Contemporary OB/GYN Staff

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Thank you for visiting the Contemporary OB/GYN website. Take a look at some of our top stories from the past week (Monday, August 10, to Friday, August 14, 2026) and click on each link to read and watch anything you may have missed.

March of Dimes: 1 in 3 US counties remain maternity care deserts

One in 3 counties in the United States remain classified as maternity care deserts, home to 2.4 million women of reproductive age, as at least 96 labor and delivery unit closures have been reported across 35 states since January 2024, according to the "Nowhere to Go: Maternity Care Deserts Across the U.S." 2026 report released by March of Dimes.
Click here for the full article.

Liz Miracle, PT, on benefits of virtual pelvic floor physical therapy

Clinician interviews conducted alongside a large retrospective outcomes analysis surfaced recurring advantages for virtual pelvic floor physical therapy care, including improved access, psychological safety, and real-time assessment in the patient's own environment, according to Liz Miracle, PT, MPT, WCS, pelvic floor physical therapist board-certified in pelvic and women's health, and Head of Clinical Quality, Origin.
Click here to watch.

Phase 2 data: ABCL635 reduces frequency, severity of VMS symptoms

AbCellera announced positive top-line results from the phase 2 portion of its phase 1/2 clinical trial evaluating ABCL635, an investigational neurokinin 3 receptor (NK3R) antagonist antibody being developed as a non-hormonal, long-acting, subcutaneous treatment for moderate-to-severe vasomotor symptoms (VMS) because of menopause, with the study meeting its primary efficacy endpoints for both frequency and severity versus placebo.
Click here for full study details.

Type 2 diabetes linked to greater menopause symptom burden in postmenopausal women

Women with type 2 diabetes mellitus reported a higher number of menopause symptoms and greater symptom severity compared with non-diabetic women, with statistically significant differences observed specifically in the postmenopause stage, according to a new study published in Menopause, the journal of The Menopause Society.
View the details here.